Nalu Medical Publishes Largest Real-World Data Study on Permanent PNS Device for Chronic Pain Management
The publication of Nalu Medical’s Real-World Data (RWD) paper in the Chronic Pain and Management Journal marks a pivotal moment in the field of pain management. This milestone establishes Nalu’s peripheral nerve stimulation (PNS) therapy as a medically necessary and highly effective treatment for chronic pain. With its groundbreaking findings, the study underscores the potential of PNS to transform how chronic pain is managed—offering hope to millions of patients worldwide.
Largest Dataset of Its Kind: A Testament to Effectiveness
The RWD analysis encompasses data from 2,273 patients who received the Nalu micro-IPG™ PNS System, making it the largest published real-world dataset on a permanent PNS device. The sheer scale of this study provides robust evidence of the system’s consistent performance across diverse patient populations. Notably, the responder rate—a measure of patient-reported improvement—was an impressive 94%, as evaluated using the highly respected Patient Global Impression of Change (PGIC) scale.
This remarkable effectiveness aligns with the findings of the COMFORT Randomized Controlled Trial (RCT), which demonstrated outstanding outcomes at the one-year mark. By corroborating these earlier results with real-world data, Nalu’s latest study strengthens the case for the widespread adoption of PNS therapy. The large sample size also supports the generalizability of the findings, suggesting that the benefits observed are applicable to the broader population of chronic pain sufferers.
Cost-Effectiveness and Broader Implications
In addition to demonstrating clinical efficacy, the study highlights the cost-saving potential of Nalu’s PNS therapy. Published data indicates that patients receiving the Nalu micro-IPG™ PNS System experienced a 50% reduction in total healthcare costs. These findings provide compelling evidence for private insurers to expand coverage for PNS treatments. By reducing reliance on costly medications, surgeries, and other interventions, Nalu’s technology offers a financially sustainable solution for managing chronic pain.
Dr. John Hatheway, the lead author of the paper, emphasized the broad applicability of the findings: “The consistent improvements observed across a large, diverse sample of real-world clinic patients—treated in multiple anatomic regions and nerve combinations—underscore the versatility of PNS therapy delivered by the Nalu micro-IPG PNS System.” This adaptability positions Nalu’s technology as a versatile tool capable of addressing a wide range of chronic pain conditions.
A Paradigm Shift in Pain Management
Tom West, President and CEO of Nalu Medical, expressed enthusiasm about the implications of the study: “These real-world results provide unmistakable evidence that the Nalu micro-IPG PNS System is dramatically reshaping pain management. No permanent PNS system has undergone greater scrutiny or shown comparable performance. We are thrilled to see that our groundbreaking technology is able to provide reliable long-term pain relief to such a broad spectrum of patients.”
Indeed, the Nalu micro-IPG™ PNS System represents a paradigm shift in chronic pain management. Unlike traditional treatments that often involve invasive surgeries or addictive medications, Nalu’s minimally invasive approach delivers gentle electrical pulses to modulate pain signals before they reach the brain. This innovative mechanism addresses a critical unmet need in the treatment of chronic neuropathic pain while offering a differentiated value proposition for both patients and physicians.
About Nalu Medical: Revolutionizing Chronic Pain Solutions
Headquartered in Carlsbad, California, Nalu Medical is a leader in developing cutting-edge, minimally invasive solutions for chronic neuropathic pain. The company’s flagship product, the Nalu Neurostimulation System, is designed to provide safe, effective, and long-lasting pain relief. By targeting the root cause of pain through precise nerve modulation, the system offers a viable alternative to conventional therapies that often fall short in delivering sustained results.
Nalu’s commitment to innovation and patient-centric care has positioned the company at the forefront of the medical technology industry. As the demand for non-opioid pain management solutions continues to grow, Nalu’s groundbreaking work is paving the way for a future where chronic pain no longer dictates patients’ quality of life.
Why This Matters for Patients and Healthcare Providers
For patients living with chronic pain, the Nalu micro-IPG™ PNS System offers renewed hope for relief without the risks associated with opioids or invasive procedures. For healthcare providers, the system represents a reliable, evidence-based option that can improve patient outcomes while reducing overall healthcare costs. By bridging the gap between clinical research and real-world application, Nalu is setting a new standard for what is possible in pain management.
